Olympian Clinical Research

JUNE 10, 2022

This impacts the skin’s ability to protect against irritants, bacteria, and allergens. However, If you are looking for additional relief, you may want to consider enrolling in a clinical trial. Clinical research studies are vital to developing new treatments and may provide relief for those struggling to reduce their symptoms.

Allergies 98

Allergies Clinical Trials Clinical Trials Clinical Research 98

Olympian Clinical Research

NOVEMBER 16, 2022

According to the American Academy of Dermatology , scientists believe that when a hair follicle becomes clogged with keratin, bacteria breed within it. When a hair follicle has more keratin and bacteria than it can hold, it bursts, causing the cyst-like breakout associated with HS. Clinical Research on Hidradenitis Suppurativa.

Clinical Research 52

Clinical Research Bacteria Dermatology Immune Response 52

Olympian Clinical Research

SEPTEMBER 22, 2022

Wearing the same pair of socks day after day may lead to the build-up of sweat and bacteria. Participate in a Clinical Trial on Toenail Fungus at Olympian Clinical Research. At Olympian Clinical Research , we are committed to helping people find new and effective treatment options for toenail fungus.

Clinical Research 52

Clinical Research Clinical Trials Clinical Trials Contamination 52

Delveinsight

NOVEMBER 26, 2020

The drug is presently delivered intravenously, so an inhaled version could make it possible for treating patients outside of a hospital or clinic. The latter can usually resist Pseudomonas infections, but as they target a broad spectrum of bacteria, can also contribute to the increase of antibiotic-resistant bugs. Clancy, M.D.,

Antibody 79

Antibody Trials Drugs Engineer 79

The Pharma Data

JANUARY 24, 2021

Their world-class physicians set new standards in comprehensive urologic patient care and continue to innovate with the most advanced treatments backed by clinical research. FACOS, Director of Clinical Research for MU stated “We are excited to work with Theralase for the NMIBC clinical study. Dr. Laurence H.

Bacteria 52

Bacteria Containment Clinical Research Research 52

Olympian Clinical Research

NOVEMBER 6, 2023

A gentle cleanser can help remove dirt, bacteria, and excess oils without stripping the skin of its natural protective barrier. Contribute to Hidradenitis Suppurativa Breakthroughs At Olympian Clinical Research, we’re passionate about making a difference for those with HS.

Hormones 52

Hormones Doctors Doctor Clinical Trials 52

Pfizer

FEBRUARY 16, 2023

GCP is the international ethical and scientific quality standard for clinical trials that all clinical researchers need to follow. OspA is a surface protein expressed by the bacteria when present in a tick. These standards are designed to put participants’ interests first and ensure high scientific integrity.

Clinical Trials 76

Clinical Trials Clinical Trials Vaccine Vaccination 76

The Pharma Data

OCTOBER 22, 2020

Iterum Therapeutics is advancing its first compound, sulopenem, a novel penem anti-infective compound, in Phase 3 clinical development with an oral formulation and IV formulation. Sulopenem has demonstrated potent in vitro activity against a wide variety of gram-negative, gram-positive and anaerobic bacteria resistant to other antibiotics.

In-Vitro 40

In-Vitro Clinical Trials Clinical Trials Clinical Development 40

WCG Clinical

SEPTEMBER 26, 2023

We’re here today to talk about clinical research with psychedelic drugs. FDA published its first draft guidance on this topic in June in response to an increasing interest in clinical trials of psychedelic drugs to treat a range of diseases. Right now, we just aren’t touching at all. We’ve never seen before.

Research 59

Research Drugs Trials Clinical Research 59

AuroBlog - Aurous Healthcare Clinical Trials blog

APRIL 11, 2024

Using viruses that infect bacteria to detect proteins sprouted by a notorious parasite, scientists have honed in on possible vaccine targets for schistosomiasis, a neglected tropical disease that currently affects an estimated 600 million people worldwide, causing 280,000 deaths per year.

Vaccine 240

Vaccine Vaccination Bacteria Protein 240

AuroBlog - Aurous Healthcare Clinical Trials blog

JANUARY 11, 2024

Researchers have identified an entirely new class of antibiotic that can kill bacteria that are resistant to most current drugs.

Bacterium 242

Bacterium Bacteria Drugs Research 242

The Pharma Data

OCTOBER 14, 2020

The new services have been developed to support pre-clinical research by optimizing hiPSC-derived cell culture, while providing high-quality electrophysiological data acquisition and analysis from physiologically relevant human cell models. Axol Bioscience – Based in the U.K., million to complete the hit-to-lead stage and up to USD 15.82

Clinical Trials 52

Clinical Trials Clinical Trials Manufacturing In-Vivo 52

The Pharma Data

DECEMBER 23, 2020

The company said the new knowledge to be generated from the extended collaboration will help further de-risk and accelerate development of Ilya’s pipeline of advanced therapies based on modified lactic acid bacteria expressing human chemokines beyond acute skin wounds to diabetic wounds and inflammatory bowel disease.

Drugs 52

Drugs Licensing Licensing Vaccine 52

AuroBlog - Aurous Healthcare Clinical Trials blog

MARCH 4, 2025

Illustration of diverse bacteria in the gut. ChrisChrisW/Getty Images) Multiple sclerosis is a disease that results when the immune system mistakenly attacks the brain and spinal cord. It affects nearly one million people in the US and over 2.8 million worldwide.

Bacteria 130

Bacteria Development Genetics Clinical Trials 130

Delveinsight

SEPTEMBER 7, 2021

Forte Biosciences’ lead asset fails in phase II clinical trials for Atopic Dermatitis. California-based pharma company Forte has been testing FB-401 , which comprises three therapeutic strains of a commensal gram-negative bacteria, as a possible therapy for atopic dermatitis.

Vaccine 70

Vaccine Vaccination Antibody Trials 70

XTalks

DECEMBER 17, 2021

Developing a highly effective vaccine against malaria has been technically challenging because malaria has a large and complex genome, and it’s why it’s generally more difficult to develop a vaccine against parasites than smaller viruses and bacteria.

Life Science 98

Life Science Vaccine Vaccination Trials 98